About Sanfilippo Foundation Switzerland
The Sanfilippo Foundation Switzerland is a non-profit organization whose mission is to facilitate, develop, finance and promote any scientific research aiming to bring efficient therapeutic solutions to children affected by mucopolysaccharidosis, and more particularly of type III. The mucopolysaccharidoses (MPS disorders) are a group of rare genetic disorders caused by the deficiency of one of the lysosomal enzymes, resulting in an inability to metabolize complex carbohydrates (mucopolysaccharides) into simpler molecules. High concentrations of mucopolysaccharides in the cells of the central nervous system, including the brain, cause the neurological and developmental deficits that accompany these disorders. MPS-III (Sanfilippo syndrome) is one of seven MPS disorders. It is an inborn error of metabolism that is transmitted as an autosomal recessive genetic disorder.